Garg K - Search Results

1

Oncologic imaging end-points for the assessment of therapy response.

Serkova NJ, Garg K, Bradshaw-Pierce EL. Serkova NJ, et al. Among authors: garg k. Recent Pat Anticancer Drug Discov. 2009 Jan;4(1):36-53. doi: 10.2174/157489209787002434. Recent Pat Anticancer Drug Discov. 2009. PMID: 19149687 Review.

2

Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy.

Diot Q, Kavanagh B, Vinogradskiy Y, Garg K, Gaspar L, Miften M. Diot Q, et al. Among authors: garg k. Med Phys. 2015 Nov;42(11):6477-87. doi: 10.1118/1.4932624. Med Phys. 2015. PMID: 26520737 Clinical Trial.

3

Successful treatment of disseminated Rosai-Dorfman disease with siltuximab.

Lee H, King G, Garg K, Pan Z, Tobin J, Robinson WA. Lee H, et al. Among authors: garg k. Haematologica. 2018 Jul;103(7):e325-e328. doi: 10.3324/haematol.2018.188441. Epub 2018 Mar 29. Haematologica. 2018. PMID: 29599203 Free PMC article. No abstract available.

4

Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung.

Roy S, Pathy S, Kumar R, Mohanti BK, Raina V, Jaiswal A, Taywade S, Garg K, Thulkar S, Mohan A, Mathur S, Behera D. Roy S, et al. Among authors: garg k. Nucl Med Commun. 2016 Feb;37(2):129-38. doi: 10.1097/MNM.0000000000000422. Nucl Med Commun. 2016. PMID: 26544097 Clinical Trial.

5

Helical CT scanning in the diagnosis of pulmonary embolism.

Garg K, Macey L. Garg K, et al. Respiration. 2003 May-Jun;70(3):231-7. doi: 10.1159/000072001. Respiration. 2003. PMID: 12915739

6

Interval lung cancer after a negative CT screening examination: CT findings and outcomes in National Lung Screening Trial participants.

Gierada DS, Pinsky PF, Duan F, Garg K, Hart EM, Kazerooni EA, Nath H, Watts JR Jr, Aberle DR. Gierada DS, et al. Among authors: garg k. Eur Radiol. 2017 Aug;27(8):3249-3256. doi: 10.1007/s00330-016-4705-8. Epub 2017 Jan 3. Eur Radiol. 2017. PMID: 28050695

7

Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.

Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, Misumi S, Kwon KS. Jin GY, et al. Among authors: garg k. Radiology. 2013 Aug;268(2):563-71. doi: 10.1148/radiol.13120816. Epub 2013 Mar 19. Radiology. 2013. PMID: 23513242 Free PMC article. Clinical Trial.

8

Overdiagnosis in low-dose computed tomography screening for lung cancer.

Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR; NLST Overdiagnosis Manuscript Writing Team. Patz EF Jr, et al. JAMA Intern Med. 2014 Feb 1;174(2):269-74. doi: 10.1001/jamainternmed.2013.12738. JAMA Intern Med. 2014. PMID: 24322569 Free PMC article. Clinical Trial.

9

Baseline characteristics of participants in the randomized national lung screening trial.

National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Clapp JD, Clingan KL, Gareen IF, Lynch DA, Marcus PM, Pinsky PF. National Lung Screening Trial Research Team, et al. J Natl Cancer Inst. 2010 Dec 1;102(23):1771-9. doi: 10.1093/jnci/djq434. Epub 2010 Nov 22. J Natl Cancer Inst. 2010. PMID: 21119104 Free PMC article. Clinical Trial.

10

Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.

Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T. Maldonado F, et al. Among authors: garg k. Am J Respir Crit Care Med. 2015 Sep 15;192(6):737-44. doi: 10.1164/rccm.201503-0443OC. Am J Respir Crit Care Med. 2015. PMID: 26052977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

996 results

Search Page